Suppr超能文献

微腺瘤的手术结果。

Surgical results in microadenomas.

作者信息

Giovanelli M, Losa M, Mortini P, Acerno S, Giugni E

机构信息

Department of Neurosurgery, San Raffaele IRCCS, University of Milano, Italy.

出版信息

Acta Neurochir Suppl. 1996;65:11-2. doi: 10.1007/978-3-7091-9450-8_4.

Abstract

Pituitary microadenomas are small tumors whose maximal diameter is less than 1 cm. The aim of surgical removal of microadenomas should be not only the reversal of hormone hypersecretion but also the preservation of normal anterior pituitary function. Our series includes 230 patients with a microadenoma who had their first operation in our department: 45 were GH-secreting, 92 were PRL-secreting, 90 were ACTH-secreting, and 3 were TSH-secreting. Remission of disease was achieved in 81%, 77%, 91%, and 100% of GH-, PRL-, ACTH-, and TSH-secreting adenomas, respectively. There was no perioperative mortality and only 5 patients experienced a major complication. A total of 7 patients had diabetes insipidus for at least 6 months after operation. Hypopituitarism, not present in any patients before operation, developed in 3.5% of the cases. Our experience confirms that patients with microadenomas have the best chances of a successful operation. Since tumor size should gradually increase with time, we underscore the need of early diagnosis and treatment in patients with pituitary adenomas.

摘要

垂体微腺瘤是最大直径小于1厘米的小肿瘤。手术切除微腺瘤的目的不仅应是逆转激素分泌过多,还应是保留正常的垂体前叶功能。我们的系列研究包括230例在我科首次接受手术的微腺瘤患者:45例分泌生长激素,92例分泌催乳素,90例分泌促肾上腺皮质激素,3例分泌促甲状腺激素。分泌生长激素、催乳素、促肾上腺皮质激素和促甲状腺激素的腺瘤分别有81%、77%、91%和100%实现了疾病缓解。无围手术期死亡,仅5例患者发生严重并发症。共有7例患者术后至少6个月出现尿崩症。术前无垂体功能减退的患者中,有3.5%出现了垂体功能减退。我们的经验证实,微腺瘤患者手术成功的机会最大。由于肿瘤大小应随时间逐渐增加,我们强调垂体腺瘤患者早期诊断和治疗的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验